Universitair Ziekenhuis Leuven, often shortened to UZ Leuven, is an academic hospital in Leuven, Belgium, associated with the university KU Leuven. It consists of five campuses as of 2016; Gasthuisberg, Lubbeek, Pellenberg, Sint-Pieter and Sint-Rafaël. The hospital has 1,995 beds and over 9,000 employees.

There are 1,995 beds in Philip Van Damme.

During the past decade, Philip Van Damme conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Philip Van Damme" are "Amyotrophic Lateral Sclerosis" (2 trials). Many other conditions were trialed in "Philip Van Damme" in a lesser frequency.

Most popular intervention types in "Philip Van Damme" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "sNN0029" (1 trials) and "sNN0029 infusion solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Philip Van Damme" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Philip Van Damme". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Philip Van Damme, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Philip Van Damme, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".